Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce that the National Association of Testing Authorities (NATA) of Australia has approved the continuation of the Company s ISO 17025 accreditation.
Proteomics International Laboratories Ltd is pleased to announce that the National Association of Testing Authorities of Australia has approved the continuation of the Company s ISO 17025. | April 16, 2023
Proteomics International Laboratories Ltd is pleased to announce its latest results for its potential new world-first blood test for diagnosing endometriosis. The results indicate strong diagnostic. | March 24, 2023
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce its latest results for its potential new world-first blood test for diagnosing endometriosis.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to invite shareholders, investors and interested parties to an online update on the recent announcement regarding the application for PromarkerD s listing on the Australian Medicare Benefits Schedule hosted by MD, Dr Richard Lipscombe.